Author:
Fujita Takuo,Ohue Mutsumi,Fujii Yoshio,Miyauchi Akimitsu,Takagi Yasuyuki
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference17 articles.
1. O’Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA (1990) Treatment of Paget’s disease of bone with aminohydroxybutylidene—bisphosphonate. J Bone Miner Res 5:483–491
2. Giannakenas C, Kalofonos HP, Apostolopoulos DJ, Zarakovitis J, Kosmas C, Vassilakos PJ (2000) Preliminary results of the use of Re186 HEDP for palliation of pain with metastatic bone disease. Am J Clin Oncol 23:83–88
3. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackay J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y (2001) Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma : a phase III, double blind, comparative trial. Cancer J 7:377–387
4. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569–4575
5. Glorieux FH (2000) Bisphosphonate therapy for severe osteogenesis imperfecta. J Pediat Endocrinol Metab Suppl 2:989–992
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献